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ABSTRACT OF DISSERTATION

IMPACT OF PTSD ON HCV/HIV RISK-REDUCTION INTERVENTIONS AMONG
INCARCERATED DRUG-USING WOMEN IN RURAL APPALACHIA
Justice-involved women in rural Appalachian Kentucky are a particularly

vulnerable group in need of targeted risk-reduction interventions for hepatitis C virus
(HCV) and human immunodeficiency virus (HIV). Compared to women in the general
U.S. population, justice-involved women in rural Appalachia report dramatically higher
rates of HCV/HIV risk behaviors (e.g., injection drug use and risky sex), interpersonal
violence (IV; e.g., physical, sexual, or emotional abuse), and posttraumatic stress disorder
(PTSD). IV and PTSD may exacerbate rural Appalachian women’s risk for contracting
and transmitting HIV/HCV, indicating a need to approach HCV/HIV risk-reduction
interventions from a trauma-informed perspective.
Brief motivational interviewing and psychoeducation interventions have both
demonstrated efficacy in decreasing HCV/HIV risk behaviors among incarcerated
women, including those with IV histories. Yet, few studies have considered the impact of
PTSD on the effectiveness of these interventions. Therefore, this study aimed to examine
the impact of PTSD on the effectiveness of HCV/HIV risk-reduction interventions
administered to incarcerated rural Appalachian women with IV histories.
Participants included a sample of 320 IV-exposed women who were enrolled in
the Women’s Intervention to Stop HIV and HCV study. Women were randomized to
receive an enhanced motivational interviewing-based HCV/HIV intervention or a
standard HCV/HIV psychoeducational intervention while they were incarcerated.
Women were then followed at 3, 6, and 12 months after being released into the
community.
Our findings indicate women’s change in HCV/HIV risk behavior after being
released from jail did not differ based on whether they received a brief psychoeducation
alone or enhance with motivational interviewing while incarcerated. Moreover, PTSD
symptoms were not associated with women’s change in injection drug or sexual risk
behavior after community re-entry. PTSD symptoms trended toward decreasing more
during re-entry for women who received a motivational-interviewing enhanced
intervention compared to women who received psychoeducation alone, although this

should be interpreted with caution. An unexpected finding was that anxiety and
depressive symptoms prior to and during incarceration were associated with different
trajectories of change in sexual, but not injection drug, risk behavior post-release.
Results from this study address the call for evidence-based HCV/HIV
interventions to be evaluated through a trauma-informed perspective and can inform
targeted prevention and intervention efforts aimed at reducing HCV/HIV risk behaviors
among rural Appalachian women.
KEYWORDS: hepatitis c virus, human immunodeficiency virus, posttraumatic stress
disorder, interpersonal violence, rural Appalachia, incarceration
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CHAPTER 1.
1.1

INTRODUCTION

Background
Reducing the spread of hepatitis C virus (HCV) and human immunodeficiency virus

(HIV) in rural Appalachian Kentucky (KY) is an urgent public health priority. Out of every
100,000 Kentuckians, currently 1,250 live with HCV and 196 live with HIV (AIDSVu,
n.d.; HepVu, n.d.). Despite national and state-level public health initiatives aimed at
reducing the contraction and transmission of HCV and HIV in KY, new HCV diagnoses
increased by 160% in the past decade while diagnoses of HIV stagnated (Northern
Kentucky Health Department, 2017; Kentucky Department for Public Health, 2019). From
2008-2015, KY had the highest rate of new HCV infections in the nation (Kentucky
Department for Public Health, 2017). Fifty-four counties in KY’s Appalachian region are
either at risk for or are currently experiencing an HCV or HIV outbreak, which accounts
for 24.5% of all at-risk counties nationwide despite representing only 1.7% of total counties
in the U.S. (Van Handel et al., 2016). The high rates of injection opioid and other drug use
in rural Appalachian KY increases these communities’ vulnerability to the rapid spread of
HCV and HIV (Moody et al., 2017; Zibbell et al., 2015).
Justice-involved women in rural Appalachian KY are a unique and particularly
vulnerable group in need of targeted interventions aimed at reducing the spread of HCV
and HIV. Both injection drug use and sexual activity are established risk factors for HIV
(Moody et al., 2017; Perlman et al., 2015; Zibbell et al., 2015). Among KY women newly
diagnosed with HIV, one-third report injection drug use and two-thirds report heterosexual
contact as the route of transmission (AIDSVu, n.d.). Injection drug use is also a risk factor
for HCV, yet the role of sexual activity in the spread of HCV is less clear. Although the
1

risk of HCV transmission between members of monogamous heterosexual couples is low,
HCV risk increases for women who engage in sexual risk behaviors (e.g., sex with multiple
partners, sex under the influence of alcohol and/or drugs, sex in exchange for drugs and/or
money, sex with high-risk partners) and for women who are co-infected with HIV or other
sexually transmitted infections (Tohme & Holmberg, 2010). Compared to women in the
general U.S. population, rural Appalachian women involved with the criminal justice
system report dramatically higher rates of recent injection drug use (2% vs. 60%) and
sexual risk behaviors (4% vs. 80%; Lansky et al., 2014; Staton et al., 2017, 2018a, 2018b,
2018c; Women’s Health USA, 2012), which exemplifies their need for targeted HCV/HIV
risk-reduction interventions.
Periods of incarceration represent an underutilized intervention opportunity for rural
Appalachian women—a group that represented the fastest-growing offender segment in
the KY criminal justice system (Vera Institute of Justice [VIJ], 2019). Since 1980, the
percent of women incarcerated in KY jails and prisons increased by 1,694% and 2,317%,
respectively (VIJ, 2019). On a national scale, KY ranks second in the number of currently
incarcerated women (The Sentencing Project, 2019). Although KY women are more likely
to serve out their sentences in county jails rather than state prisons, county jails often
provide less access to services, including healthcare and substance use treatment programs
(Kentucky Legislative Research Commission, 2017). Correctional facilities in rural
Appalachia house an unprecedented number of women at high risk for deleterious health
outcomes, including HCV and HIV. Given that Appalachian women face multiple barriers
to preventative care, including living in a remote geographical location, having limited
access to health services, and lacking insurance coverage (Moody et al., 2017; Staton et al.,
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2001; Staton-Tindall et al., 2007; Stephens et al., 2017), periods of incarceration represent
an essential intervention opportunity.
Brief interventions administered to incarcerated women reduce HCV and HIV risk
behaviors (Staton et al., 2017, 2018b). Two evidence-based approaches that have
demonstrated efficacy in reducing HCV/HIV risk behaviors include NIDA Standard HIV
Education (HIV-Ed) and Motivational Interviewing-based HIV Risk-reduction (HIV+MI).
The HIV-Ed was developed through large, multisite cooperative agreement trials and aims
to provide education on safe practices for injection drug use (e.g., identifying unsafe drug
use, discussing needle and drug equipment cleaning strategies) and sexual activity (e.g.,
identifying unsafe sex, encouraging condom use and communication with partners; Coyle,
1998). The HIV+MI intervention is grounded in the Transtheoretical Model of Health
Behavior Change, which conceptualizes the process of behavior change as taking place in
stages over time (e.g., precontemplation, contemplation, preparation, action, maintenance,
termination; Prochaska et al., 2008; Prochaska & Velicer, 1997). Motivational interviewing
is a validated therapeutic technique that facilitates the transition through the stages of
change by incorporating patient-centered counseling techniques (e.g., reflective listening)
and identifying discrepancies between life goals and current behavior (Miller & Rollnick,
2002). Thus, the goal of HIV+MI is to reduce ambivalence and strengthen motivation
toward behavior change and thereby reduce HCV/HIV risk behaviors. Comparative
effectiveness studies show that both HIV+MI and HIV-Ed demonstrate considerable and
comparable reductions in HCV/HIV risk behavior among women from rural Appalachia
and women in urban settings (Staton et al., 2018b; Weir et al., 2009).

3

Research conducted in justice-involved rural Appalachian women highlights the
need to adopt a trauma-informed perspective (Facer-Irwin et al., 2019; Levenson & Willis,
2019), which recognizes the widespread impact of trauma and its effect on potential paths
for recovery (Substance Abuse and Mental Health Services Administration [SAMHSA],
2014). The lifetime prevalence of interpersonal violence (IV)—or physical, sexual, and
emotional abuse (Rosenberg et al., 2006)—and posttraumatic stress disorder (PTSD;
American Psychiatric Association [APA], 2013) are substantially elevated among
incarcerated women in this region relative to women in the general U.S. population (IV:
80% vs. 46%; PTSD: 67% vs. 10%; Iverson et al., 2013; Mitchell et al., 2012; Staton et al.,
2018b). Indeed, IV is associated with poorer perceived ability to negotiate safe sex and
injection practices with partners (Mittal et al., 2013; Teitelman et al., 2008; Wagner et al.,
2009), and PTSD symptoms mediate the association between IV and HCV/HIV risk
behaviors (Cavanaugh et al., 2010; Plotzker et al., 2007). Additionally, individuals with
PTSD demonstrate poorer outcomes in substance use treatment (Kubiak, 2004; Read et al.,
2004), worse adherence to HIV antiretroviral therapy (Delahanty et al., 2004), and a need
for enhanced monitoring while undergoing interferon-based therapies for HCV (Loftis et
al., 2006). From a trauma-informed perspective, PTSD symptoms may exacerbate risk for
HCV/HIV contraction and transmission in justice-involved rural Appalachian women.
However, it is unknown to what extent brief HCV/HIV risk-reduction interventions are
effective for justice-involved women with PTSD.
Symptoms of PTSD affect a large proportion of justice-involved rural women and
may interfere with current efforts to reduce HCV/HIV risk behaviors. One of the defining
characteristics of PTSD is avoidance of trauma reminders (APA, 2013). Individuals with
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PTSD may use substances and engage in risky sexual behavior to cope with or avoid their
PTSD symptoms (McCauley et al., 2012; Weiss et al., 2013). Thus, rural Appalachian
women with PTSD symptoms may not benefit from brief HCV/HIV risk-reduction
interventions to the same extent as women without PTSD, as these risk behaviors may be
inextricably linked with their ability to cope with trauma-related distress. Yet, preliminary
findings suggest that motivational interviewing attenuates risk for developing PTSD
following trauma exposure (Zatzick et al., 2004), enhances PTSD treatment outcomes
(Randall & McNeil, 2017), and may reduce PTSD symptoms (Battaglia et al., 2016). Since
motivational interviewing is founded upon facilitating behavior change, HCV/HIV riskreduction interventions that include a motivational interviewing component may offer
more promise than standard psychoeducational interventions for IV-exposed incarcerated
women with PTSD.

1.2

Study Aims
This study addresses a critical gap in efforts to reduce injection drug use and risky

sexual behavior among incarcerated women from rural Appalachia—a uniquely vulnerable
and disadvantaged population at high risk for deleterious health outcomes—by examining
HCV/HIV risk-reduction interventions through a trauma-informed perspective (FacerIrwin et al., 2019; Levenson & Willis, 2019; SAMHSA, 2014). More specifically, the
present study addresses a significant gap in knowledge by (1) examining the effect of PTSD
symptoms on evidence-based interventions that target HCV/HIV risk behavior
administered to incarcerated women with IV histories and (2) evaluating the relationship
between PTSD symptoms and HCV/HIV risk behavior during the community re-entry
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period. The aims of the project were executed by examining secondary longitudinal data
from the Women’s Intervention to Stop HCV/HIV study (WISH; NCT01840722;
R01DA033866). The sample included 320 women with lifetime IV randomized to receive
the NIDA Standard HIV Education alone (HIV-Ed) or the NIDA Standard HIV Education
plus the Motivational Interviewing-based HIV Risk-reduction intervention (HIV+MI)
while incarcerated. Participants were then followed at 3-, 6-, and 12-months following
release from jail.
The first aim was to examine to what extent PTSD symptoms prior to incarceration
predicted HCV/HIV risk behavior following community re-entry. We expected that higher
PTSD symptoms prior to incarceration would predict higher rates of injection drug and
sexual risk behavior post-release (Hypothesis 1a). We also hypothesized that women with
higher PTSD symptoms prior to incarceration who received the enhanced HIV+MI
intervention would report lower rates of injection drug use and risky sexual behavior postrelease relative to women with similar levels of PTSD in the HIV-Ed condition (Hypothesis
1b).
The second aim of the study was to evaluate the extent to which reductions in PTSD
symptoms following community re-entry predicted reductions in HCV/HIV risk behavior.
We expected that women who received the HIV+MI intervention would demonstrate
greater reductions in PTSD symptoms post-release relative to women in the HIV-Ed
condition (Hypothesis 2a). We also hypothesized that PTSD symptom reduction would
prospectively predict lower rates of injection drug use and risky sexual behavior
(Hypothesis 2b). Findings from this study will inform targeted prevention and intervention
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efforts aimed at reducing HCV/HIV risk behaviors among justice-involved rural
Appalachian women with IV histories.

7

CHAPTER 2.
2.1

METHODS

Participants
Participants included a subsample of women who were enrolled in the WISH study

who reported a lifetime history of IV during the baseline interview. Women enrolled in the
parent project were incarcerated in three rural Appalachian jails. Briefly, women were
eligible for the study if they endorsed moderate need for a substance use intervention and
reported at least one sexual risk behavior in the three months before incarceration (full
eligibility criteria are described below). Women in the subsample were, on average, 33.0
years of age (SD = 8.1), and almost all women reported their race as white (99.1%). Most
women earned their high school diploma or GED (58.1%). One-third of women were
married (31.3%) and most women (87.5%) had children. Demographic characteristics for
the full sample are summarized elsewhere (Staton et al., 2018b).

2.2

Measures
Interviews were administered by trained personnel during incarceration (baseline)

and at 3-, 6-, and 12-months following re-entry into the community (follow-up).
However, it should be noted that not all measures were administered at every time point
(see Table 2).
A modified version of the Risk Behavioral Assessment (RBA; Wechsberg, 1998)
was used to measure injection and sexual risk behaviors. The RBA is a brief interview that
determines risk levels for contracting HIV and other infectious diseases by assessing a
participant’s engagement in injection drug and sexual risk behaviors. Items on the modified
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RBA were anchored to assess injection drug risk behavior in the year before incarceration
(assessed at baseline) or since the last follow-up assessment. The modified RBA included
the following items for injection drug risk behavior: (1) injected drugs; (2) used shared
needle; (3) used shared works; (4) shared needles; (5) shared works; (6) shared injection
equipment with sex partner; (7) did not always inject first. Items on the modified RBA
measuring sexual risk behaviors include the following acts with the participant’s last main
or casual partner: (1) did not use condom the entire time during last vaginal sex; (2) did
not use condom the entire time during last anal sex; (3) used alcohol/drugs before or during
last sex; (4) last partner has history of injecting drugs; (5) traded sex for drugs, money, etc.
with last casual partner. In prior studies on individuals who use substances, the RBA
demonstrated acceptable reliability and validity (Wechsberg et al., 2004).
The Global Appraisal of Individual Needs (GAIN; Dennis et al., 2008) was used to
assess PTSD and other comorbid psychiatric symptoms (i.e., anxiety and depression), as
well as experiences of IV. The GAIN is a comprehensive interview that was originally
developed for use by substance use treatment providers to make efficient mental health and
substance use diagnoses and inform treatment placement and planning. Women were asked
to what extent they experienced symptoms of PTSD, anxiety, and depression in the past 12
months at baseline or since the last assessment at the 6- and 12-month follow-up. The 12item GAIN Traumatic Stress Scale (TSS) was used to assess PTSD symptoms. Scores on
the TSS produce a total symptom count (0-12) with higher scores reflecting greater PTSD
symptom severity. The total score can be dichotomized to reflect a possible diagnosis of
PTSD (i.e., scores of >5 reflect “high traumatic stress” or possible PTSD). Given the
notable comorbidity between PTSD, mood, and anxiety disorders (Price et al., 2019), the

9

12-item GAIN Anxiety and Fear Symptom Scale (AFSS) and the 9-item Depressive
Symptoms Scale (DSS) were used to assess psychiatric conditions that are commonly
comorbid with PTSD. The AFS and DSS produce symptom counts that range from 0-12
and 0-9, respectively. The AFS and DSS scale scores were considered for inclusions as
time-invariant covariates in the primary models for Hypothesis 1a and 1b, and time-varying
covariates in models for Hypothesis 2a and 2b. Four dichotomous items (Yes/No) were
used to assess women’s experiences of lifetime sexual, physical, or emotional abuse at
baseline, and if they experienced these types of victimization since the last assessment at
the 6- and 12-month follow-up. IV during the re-entry period was also considered for
inclusion as a time-varying covariate in the models for Hypothesis 2a and 2b. Although the
GAIN is not a formal diagnostic tool, it is a reliable and valid interview that measures IV
experiences and produces provisional diagnoses of various psychiatric disorders (Dennis
et al., 2008).
At baseline, participants were also asked whether this was their first period of
incarceration. Women reported subsequent incarcerations at the follow-up assessments;
this variable was tested as a time-varying covariate in the primary models for Hypothesis
1a, 1b, and 2b.

2.3

Procedure
All study procedures were approved by the University of Kentucky’s Institutional

Review Board and participants were protected under a federal Certificate of
Confidentiality. Figure 1 displays an overview of study procedures and timeline relevant
to the current project. Informed consent was obtained from all participants in the study.
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2.3.1

Research Location and Random Selection
This study used an established approach for data collection with incarcerated

populations recommended by the National Institute of Justice (NIJ; 2003). Of the 27 jails
located in rural Appalachian KY, participating jails were selected based on geographic
location, having a daily census count above 50, and having no substance use treatment
programs for inmates. Based on these criteria, three jails were selected for study inclusion:
Perry County, Leslie County, and Laurel County. In total, there were approximately 65
women incarcerated in these jails on a given day. From 2012-2015, recruitment in each of
the three jails occurred once per month based on a randomization schedule that included
all days of the week and all times of the day, consistent with recommendations from NIJ
(2003). On each recruitment day, the targeted number of women inmates were randomly
selected from the jail’s daily census record.

2.3.2

Preliminary Screening
Screening and informed consent occurred in a private, confidential room in the jail

and lasted approximately 20 minutes. During the informed consent procedure, women were
reminded of the voluntary nature of the study. Screening measures evaluated need for
substance use intervention and sexual risk behaviors in the past three months. Women were
deemed eligible for study participation if they (1) endorsed at least moderate need for
substance use intervention as indicated by a score of >4 for any substance measured by a
modified version of the Alcohol, Smoking, and Substance Involvement Screening Test
(NM-ASSIST; National Institute on Drug Abuse, 2009); (2) reported >1 self-reported
sexual risk behavior (e.g., multiple sex partners, unprotected sex, sex under the influence
11

of alcohol or drugs) in the three months prior to incarceration as measured by three items
from the RBA (Wechsberg, 1998); (3) demonstrated no evidence of cognitive impairment,
active psychosis, or symptoms of physical substance withdrawal as measured by the GAIN
(Dennis et al., 2008); (4) were incarcerated for at least one week following screening to
complete the intervention; (5) lived in a rural Appalachian county prior to incarceration;
and (6) reported a willingness to participate.
The initial recruitment phase for the WISH project occurred between 2012-2015.
During this time, 900 incarcerated women were randomly selected for study screening, 688
(76.4%) completed screening, 440 (48.9%) were eligible at screening, and 400 (44.4%)
completed a baseline interview. Women enrolled in the WISH study were representative
of the rural Appalachian region in KY in terms of race/ethnicity. Given the association
between IV experiences and PTSD symptoms (Kilpatrick et al., 2017), a subsample of
women with IV histories (n = 320) will be used to examine the impact of PTSD symptoms
on HCV/HIV risk behavior. Demographic information and clinical characteristics of the
subsample are presented in Table 1.

2.3.3

Baseline Interview
On the same day as the initial screening, those who met eligibility criteria

completed a confidential, face-to-face interview. Trained research personnel administered
the baseline interview, which lasted approximately two hours. Jail staff were allowed to
monitor entry and exit of the private visiting room but were not permitted to be present in
the room for the confidential interview. Prior to the interview, women were reminded of
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the components of informed consent and were compensated $25 for completing the
interview.

2.3.4

Intervention
The aim of the parent project was to compare the effectiveness of two interventions

aimed at reducing HCV/HIV risk behaviors among rural Appalachian justice-involved
women (Staton et al., 2018b). Following the baseline interview, women had a 50/50 chance
of being randomly assigned to one of two intervention conditions using Research
Randomizer (www.randomizer.org). The NIDA Standard HIV Education (HIV-Ed) is a
brief, single-session intervention that focuses on HIV education related to injection drug
use (e.g., needle sharing, cleaning/bleaching injection equipment, disposal of hazardous
waste material, stopping unsafe drug use, and benefits of drug treatment) and sexual
practices (e.g., condom use, communication with sex partners, and stopping unsafe sexual
practices) consistent with CDC guidelines. Women were also taught correct condom use
and were given a list of local health and behavioral health services. The HIV-Ed occurred
prior to HCV/HIV rapid testing and counseling. All study staff were certified HIV
counselors by the Kentucky Department of Public Health.
Women randomized to receive the NIDA Standard HIV Education plus the
Motivational Interviewing-based HIV Risk-reduction (HIV+MI) were provided the same
single-session HIV Education during the baseline visit prior to HCV/HIV testing and
counseling. Participants were then invited to participate in four brief motivational
interviewing intervention sessions aimed at targeting motivation to change their injection
drug use and risky sexual behavior. Motivational interviews were conducted prior to
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release from jail. Consistent with prior research (Weir et al., 2009), the four motivational
interviewing sessions focused on (1) enhancing women’s ability to identify risky drug use
and sexual behaviors, (2) assessing women’s perceptions of risk and readiness to address
risky drug use and sexual behavior, and (3) facilitating a stage-based discussion about drug
use and sexual behavior change. The MI interventionist completed a 2-day training at the
outset of the study and participated in on-going supervision throughout the study for quality
control. Of the 166 women randomized to this condition, 111 (69.4%) completed all 4
sessions, 9 (5.6%) completed 3 sessions, 22 (13.8%) completed 1-2 sessions, 18 (11.3%)
did not complete any MI sessions. More than half (59%) of women screened positive for
HCV antibodies and no women screened positive for HIV.
2.3.5

Follow-up Data Collection

Face-to-face follow-up interviews were conducted at 3-, 6-, and 12-months postrelease from jail at a location that was mutually agreed upon by the research staff and each
study participant. Retention rates for the follow-up interviews ranged from 88-97%.

2.4

Data Analytic Plan
Chi-square tests and independent samples t-tests were used to compare whether

women’s engagement in HCV/HIV risk behaviors prior to incarceration and levels of
PTSD, anxiety, and depression in the year before baseline differed by intervention
condition.
Latent growth curve models (LGCMs) were used to examine to what extent PTSD
symptoms prior to incarceration (i.e., baseline) predicted HCV/HIV risk behavior
following community re-entry (Hypotheses 1a-1b) and to evaluate the extent to which
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reductions in PTSD symptoms following community re-entry predicted reductions in
HCV/HIV risk behavior (Hypotheses 2a-2b). This analytic approach is conceptualized in
a structural equation analytic framework where initial states and change over time are
depicted in the form of latent growth factors (e.g., intercept and slope; Duncan & Duncan,
2009). The growth factors are latent in that they are not directly observed but are
hypothesized to cause the observed outcomes over time. LCGMs are appropriate for
longitudinal designs with repeated correlated observations and are robust to missing data,
differing numbers of observations across participants, and unequally spaced time intervals
(Curran et al., 2010). More specifically, LGCM can account for missing data using full
information maximum likelihood (FIML) estimation. FIML estimates a likelihood function
for each individual based on the variables that are present so that all available data are used.
All LGCMs were conducted using Mplus Version 7.4 (Muthén & Muthén, 2015).
Models were tested using a stepped approach. First, unconditional models—or models
without predictors beyond the latent intercept and slope factors—were estimated to
examine the best form of change in the outcome variable (HCV/HIV risk behavior, PTSD)
from incarceration to community release. In other words, if participants changed on a given
outcome during re-entry, the LGCM attempts to represent the best form or rate of change
over time. Second, conditional models were tested with time-invariant and time-varying
covariates that, based on prior research and theoretical rationale, were relevant to
evaluating the primary hypotheses. TICs directly predict the latent growth factors, whereas
TVCs directly predict the repeated measure of risk behavior while controlling for the
influence of the latent growth factors (Curran et al., 2010). The deviance statistic (-2LL)
was used to test the fit of nested models when adding time-invariant and time-varying
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covariates (Schreiber et al., 2006). A significant p-value of the Chi-square deviance test
indicates that the model with smaller deviance value fits better than the model with the
larger deviance value, whereas a non-significant p-value indicates that the model with the
larger deviance value fits better (Lee et al., 2018). The conditional LGCMs allow for
estimation of between-person characteristics (interindividual differences) that predict
individual variability (intraindividual variance) in the initial states and rate of change over
time. Accounting for intraindividual variance in longitudinal designs decreases the
probability of Type I errors (Gibbons et al., 2010). To aid in conceptualization of the
LGCMs, Figure 2.2 depicts the associations among the latent growth factors of HCV/HIV
risk behaviors, time invariant covariates, and time varying covariates.
2.4.1

Hypothesis 1a and 1b
After summing responses to the individual items on the RBA that measure injection

drug and sexual risk behavior, a latent variable transformation was then used to transform
the observed ordinal indicators from the summed scores into continuous latent variables
(Lee et al., 2018). This transformation assumes that the observed ordinal indicators
(summed scores) are discretized forms of a continuous underlying latent variable. Using a
probit link function, the discretized continuum is defined by thresholds (i.e., cut points)
that represent the distance between ordinal categories. Thresholds are calculated as the zscores associated with the proportion of the standard normal that is equal to the proportion
of the sample endorsing a particular level on the ordinal scale. Thresholds are fixed to be
equal across time points to meet the longitudinal threshold assumption and ensure
measurement of the same construct over time (Masyn et al., 2013). In the LGCM with
repeated ordinal observed variables, the initial level growth factor mean (intercept) reflects
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the expected proportion of participants who engaged in the HCV/HIV risk behavior (i.e.,
their summed scores were greater than 0). The latent slope represents change in the
propensity to engage in the risk behavior over time.
Using a stepped approach, unconditional models were first estimated to examine
change in injection drug and sexual risk behavior in the year prior to incarceration
(baseline) to community release (months 3, 6, and 12). The conditional LGCMs were then
tested with time-invariant and time-varying covariates. Baseline PTSD symptoms were
entered as a time-invariant covariate in order to evaluate to what extent higher symptoms
were associated with a greater propensity for injection drug and sexual risk behavior postrelease (Hypothesis 1a). An interaction term between baseline PTSD symptoms and
intervention condition was also entered as a time-invariant covariate to examine if women
with higher PTSD symptoms prior to incarceration who received the enhanced HIV+MI
intervention would report lower rates of injection drug use and risky sexual behavior postrelease relative to those women with higher PTSD symptoms in the HIV-Ed condition
(Hypothesis 1b). Anxiety and depressive symptoms assessed at baseline were included as
time-invariant covariates to evaluate whether PTSD symptoms at baseline predicted postrelease HCV/HIV risk behavior above-and-beyond other commonly comorbid psychiatric
symptoms. HCV seropositive status was also tested as a time-invariant covariate to
evaluate the effect of the interventions above-and-beyond women’s HCV status at baseline.
Time-varying covariates included incarceration (months 3, 6, 12) and IV (months 6 and
12) since both recidivism and re-victimization may impact the extent to which participants
engage in post-release HCV/HIV risk behavior.
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2.4.2

Hypothesis 2a and 2b
The first step in the analyses for Hypothesis 2a—testing whether women who

received the HIV+MI intervention would demonstrate greater reductions in PTSD
symptoms post-release relative to women in the HIV-Ed condition—was to specify a
measurement model and examine factorial invariance of PTSD symptoms over time.
Briefly, testing measurement invariance is important so that changes in mean levels of the
construct reflect actual changes in the construct, rather than in how the construct was
measured (Little, 2013). The 12 items from the GAIN TSS were used as measured
indicators of PTSD symptoms assessed at baseline, month 6, and month 12. The benefit of
conducting a measurement model (rather than using a sum) is that this method accounts for
measurement error and correlated residuals between measured indicators (Little, 2013). A
mean- and variance-adjusted weighted least squares (WLSMV) estimation was used in the
measurement model and the comparative fit index (CFI), Tucker-Lewis index (TLI), and
root mean square error of approximation (RMSEA) were used to evaluate model fit. CFI
and TLI Values of > .95 and RMSEA values of < .06 to .08 indicate acceptable model fit
(Schreiber et al., 2006). Due to convergence issues, FIML (described above) was used
when estimating conditional PTSD models during the re-entry period.
The second step involved adding latent growth factors to the measurement model.
The intercept mean and variance were fixed to 0. Since PTSD was only assessed at three
time points (baseline, month 6, and month 12), a latent linear slope was used to estimate
change in PTSD over time. After adding the latent growth factors, the third step was to
conduct conditional models that included time-invariant and time-varying covariates.
Intervention condition was included as a time-invariant covariate. Depression and anxiety
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assessed at baseline, month 6, and month 12, as well as IV and incarceration assessed at
months 6 and 12 were included as time-varying covariates to examine the effect of
intervention condition above and beyond other factors that may impact PTSD symptoms
during the re-entry period.
To examine whether changes in PTSD prospectively predict HCV/HIV risk
behaviors during the re-entry period (Hypothesis 2b), we calculated a difference score by
subtracting the latent factor of PTSD at baseline from the latent factor of PTSD at month
6 (negative scores indicate a decrease in symptoms between these time points). This
difference score was then used to predict injection drug and sexual risk behavior at month
12, while controlling for the latent factor score of PTSD symptoms at the same time point
and including relevant time-invariant and time-varying covariates, as specified below. The
structure of these models is similar to what has already been described for Hypothesis 1a
and 1b, with the exception that the intercept was set to 0 at month 12, rather than at baseline.

2.5

Sample Size Justification
Since the current study is a secondary data analysis with a fixed sample size, a

sensitivity analysis was performed to determine the smallest effect size that could be
detected, referred to as the minimum detectable effect size (MDES). The power calculation
was computed for the most stringent analytical model—the two-way interaction between
intervention condition and PTSD presented in Aim 1. To calculate the MDES for the main
effect of PTSD and the interaction between PTSD and intervention condition (HIVEd/HIV+MI) on the slope of change over time, as specified in the first aim, a Monte Carlo
simulation with 100,000 replications was performed. For Hypothesis 1a, a sample size of
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320 women in which 70% had probable PTSD, 80% of the time a difference in slopes of B
= 0.15 was detected at α = .05. This difference in slopes corresponds to a small-medium
effect (Cohen, 1969). For Hypothesis 1b, where the interest is in the interaction between
PTSD and intervention condition, 80% of the time a difference in slopes of B = .35 was
detected at α = .05. This difference corresponds to a medium-large effect (Cohen, 1969).
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Table 2.1. Study Variables by Assessment Period
Measures
Demographics
Age, race/ethnicity, education, marital status,
parental status
Risk Behavioral Assessment - Women (RBA)
Injection drug risk behavior (in year before
incarceration or since last assessment)
Sexual risk behavior with last main and/or casual
partner
Global Appraisal of Individual Needs (GAIN)
Interpersonal violence exposure (lifetime or since
last assessment)
PTSD, anxiety, depression (in past year or since
last assessment)
Justice-involvement
Incarceration status
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Figure 2.1. Study Timeline
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Baseline
Risk Behavior

Month 3
Risk Behavior

Month 6
Risk Behavior

Baseline
TVC

Month 3
TVC

Month 6
TVC

Month 12
Risk Behavior

1
1

Intercept

1
1
0
.5

TIC

Linear
Slope

1
2
0
.25

Quadratic
Slope

1
4

Month 12
TVC

Figure 2.2. Example LGCM Estimating Change in HCV/HIV Risk Behavior during the
Community Re-entry

Note: TIC = Time-invariant covariate; TVC = time-varying covariate. The numbers beside
the latent growth factors reflect factor loadings for the latent intercept and slopes.
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CHAPTER 3.
3.1

RESULTS

Descriptive Statistics
The percentages of injection drug and sexual risk behavior and incarceration status,

as well as mean psychiatric symptom scores measured at baseline and follow-up are
reported in Table 3.1. Consistent with prior studies using the WISH sample (Staton et al.,
2018b), women’s engagement in injection drug and sexual risk behaviors in the year before
incarceration did not significantly differ by intervention condition (injection drug risk
behavior ps = .58 - .94; sexual risk behavior ps = .07 - .97). Women in the HIV+MI and
HIV-Ed conditions reported similar rates of lifetime exposure to physical, sexual, and
emotional abuse (ps = .07 - .74). Women’s PTSD (p = .06), anxiety (p = .44), and
depressive symptoms (p = .36) at baseline also did not significantly differ by intervention
condition. Overall, women’s engagement in HCV/HIV risk behaviors and their psychiatric
symptoms decreased from pre-incarceration (baseline) to community re-entry (follow-up).
Pearson correlations between PTSD, anxiety, and depressive symptoms at each time point
are presented in Table 3.2. Except for the non-significant relations between PTSD at
baseline and PTSD at month 6, PTSD at month 12, and anxiety at month 6, all other
correlations between PTSD, anxiety, and depression were positively associated.

3.2

Development of the LGCMs
We compared unconditional models using latent linear and quadratic slopes to best

estimate participants’ patterns of change in HCV/HIV risk behaviors over time (Hypothesis
1a and 1b). In the models with a linear slope, factor loadings were set to 0, .5, 1, and 2 to

reflect change in 6-month increments and account for unequally spaced assessments. The
quadratic slope models included the linear slope plus a quadratic slope term with factor
loadings of 0, .25, 1, and 4. As shown in Table 3.3, models with linear and quadratic slopes
demonstrated better fit than models with only linear slopes. Thus, models with linear and
quadratic slopes were retained for use in further analyses. For the models examining PTSD
change from baseline to month 6 as a predictor of HCV/HIV risk behavior at month 12
(Hypothesis 2b), the factor loadings for the linear and quadratic slopes were re-coded to 2, -1.5, -1, 0 and 4, 2.25, 1, 0 to set the intercept at the last assessment period.
When specifying the measurement model for PTSD (Hypothesis 2a), we tested
factorial invariance to evaluate whether the properties of the PTSD assessment were stable
across time points (Elsworth et al., 2015). Compared to a model with configural invariance,
imposing weak and strong invariance restrictions significantly worsened model fit (weak:
χ2(22) = 38.22, p = .02; strong: χ2(24) = 196.85, p < .001). We retained the unrestricted model
because it was a good fit to the data (χ2(637) = 1362.27, p < .001; RMSEA = .06; CFI/TLI =
.98/.98) and the factor loadings of each indicator were consistent across time. We can
interpret change in PTSD across time as actual change in the construct rather than how the
construct was measured. Figure 3.1 displays the standardized parameter estimates from
fitting the measurement model. Including the latent intercept and slope resulted in a model
with good fit (χ2(614) = 668.09, p = .06; RMSEA = .02; CFI/TLI = .99/.99).
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3.3
3.3.1

Primary Aims
Aim 1: Examine to what extent PTSD symptoms prior to incarceration predict
HCV/HIV risk behavior following community re-entry.

3.3.1.1 Unconditional Model for Injection Drug Risk Behavior
Results of the unconditional model are presented first to summarize the latent growth
factors for injection drug risk behavior during the re-entry period. The model-implied
observed proportions for each response category (0 to 7 injection risk behaviors) by time
point are displayed in Figure 3.2. As shown in Table 3.4, the estimated intercept mean was
significant indicating that more than 50% of women reported at least one injection drug
risk behavior (i.e., fell above the first threshold). Propensity to engage in injection drug
risk behavior significantly decreased from pre-incarceration across the re-entry period
(negative linear slope) and this decrease slowed across time (positive quadratic slope).
There was significant unexplained variance person-to-person in women’s propensity to
engage in injection drug risk behavior prior to incarceration, as well as their trajectory of
change in risk behavior during the re-entry period (positive linear and quadratic slope
variances).

3.3.1.2 Unconditional Model for Sexual Risk Behavior
The model-implied observed proportions for each response category (0 to 5
sexual risk behaviors) by time point are displayed in Figure 3.2. As shown in table 3.4,
the estimated intercept mean was significant suggesting that more than 50% of women
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reported at least one sexual risk behavior (i.e., fell above the first threshold). Propensity
to engage in sexual risk behavior significantly decreased from pre-incarceration across
the re-entry period (negative linear slope) and this decrease slowed across time (positive
quadratic slope). There was significant unexplained variance person-to-person in
women’s propensity to engage in sexual risk behavior prior to incarceration and their
trajectory of change in risk behavior during the re-entry period (positive linear and
quadratic slope variances).

3.3.1.3 Conditional Models for Injection Drug and Sexual Risk
Behavior
In the conditional LGCMs for injection drug and sexual risk behavior, each timeinvariant and time-varying covariate was entered independently, and fit statistics were
compared against the unconditional quadratic slope models (see Table 3.3). Model fit
significantly worsened after adding HCV seropositive status at baseline as a time-invariant
covariate, as well as both incarceration and IV experiences during the follow-up period as
time-varying covariates. Thus, the final conditional models for Hypothesis 1a and 1b
included the following time-invariant covariates: intervention condition; symptoms of
PTSD, anxiety, and depression; and the interaction between intervention condition and
PTSD symptoms (injection drug risk: -2LL = -1227.03; FP = 30; AIC = 2514.06; BIC =
2627.11; sexual risk: -2LL = -1672.44; FP = 28; AIC = 3400.88; BIC = 3506.40).
Table 3.4 reports the parameter estimates for the conditional LGCMs estimating
injection drug and sexual risk behavior during the re-entry period. For ease of visual
interpretation, the probabilities depicted in Figures 3.3 through 3.6 represent
dichotomized HCV/HIV risk behavior, where 0 = denied and 1 = endorsed. Figures 3.3
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and 3.4 show the non-significant effect of intervention condition on change in injection
drug and sexual risk behavior during re-entry. Although none of the time-invariant
covariates were significantly associated with the growth factors in the model estimating
injection drug risk behavior, anxiety and depression at baseline were related to sexual risk
behavior. As shown in Figure 3.5, higher baseline levels of anxiety were associated with
a greater propensity of engaging in sexual risk behavior at baseline (positive intercept
coefficient) and a steeper decline in sexual risk behavior across the re-entry period
(negative linear slope coefficient). Additionally, women with higher anxiety severity at
baseline experienced a steeper reduction in sexual risk behavior soon after release from
jail, whereas sexual risk behavior declined more steadily across the re-entry period
among those with lower anxiety symptom severity (positive quadratic slope). The
opposite pattern was found for depression (Figure 3.6): women with lower depression
severity at baseline experienced a steeper reduction in sexual risk behavior soon after
being released, whereas sexual risk-taking declined more steadily during re-entry for
women with higher anxiety symptoms (negative quadratic slope). No other time-invariant
covariates were significantly associated with the intercept or growth factors for sexual
risk behavior. Neither anxiety (B = 0.07, SE = 0.04, p = .08), nor depression (B = -0.06,
SE = 0.05, p = .23) were significantly associated with sexual risk behavior at month 12,
suggesting the effect of anxiety and depression on sexual risk-taking may dissipate as
women are farther out from periods of incarceration.

28

3.3.2

Aim 2: Evaluate the extent to which reductions in PTSD symptoms following
community re-entry predict reductions in HCV/HIV risk behavior.
3.3.2.1 Unconditional and Conditional Models for PTSD

After establishing good fit using WLSMV in the PTSD measurement model, FIML
was used in the unconditional and conditional models estimating change in PTSD over
time. In the unconditional model, PTSD symptoms significantly decreased (B = -1.50, SE
= 0.25, p < .001). There was significant unexplained variance person-to-person in women’s
rate of change in PTSD symptoms during the re-entry period (B = 2.23, SE = 0.74, p =
.003).
For the conditional LGCMs for PTSD, each time-invariant and time-varying
covariate was entered independently, and fit statistics were compared against the
unconditional linear slope model (see Table 3.5). Model fit significantly worsened after
adding HCV seropositive status as a time-invariant covariate, as well as anxiety and
depression, IV experiences, and incarceration status as time-varying covariates. Thus, the
final conditional models for Hypothesis 2a only included the intervention condition as a
time-invariant covariate (AIC = 6868.26; BIC = 6973.78). The effect of intervention
condition significantly predicted the baseline centered intercept of PTSD (B = 0.88, SE =
0.34, p = .01) which suggests that women in the HIV+MI condition had higher model
estimated PTSD symptoms in the year prior to baseline compared to women in the HIVEd condition. The effect of intervention condition on change in PTSD across the re-entry
period approached significance (B = -0.66, SE = 0.34, p = .052). As depicted in Figure 3.7,
women’s PTSD symptoms decreased -0.66 units in the HIV+MI condition than in the HIVEd condition. Additional models were run with the intercept set at each follow-up
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assessment, and results suggest women’s PTSD symptoms did not differ by intervention
condition at month 6 (B = 0.37, SE = 0.31, p = .23) or month 12 (B = -0.12, SE = 0.41, p =
.77).
3.3.2.2 Conditional Model for Change in PTSD Predicting
Change in HCV/HIV Risk Behavior
When adding the difference in factor scores between baseline PTSD and month 6
PTSD, as well as the factor score of PTSD at month 12, the model fit for both injection
drug (-2LL, FP = -1883.22, 22; χ2(df) = 645.94 (7), p < .001) and sexual risk behavior (2LL, FP = -2333.20, 20; χ2(df) = 642.97 (7), p < .001) was significantly worse compared
with the unconditional model. Change in the PTSD factor scores from baseline to month 6
did not significantly predict injection drug (B = -0.14, SE = 0.09, p = .14) or sexual risk
behavior (B = -0.06, SE = 0.08, p = .42) at month 12. However, higher PTSD factor scores
at month 12 were positively associated with a greater propensity to engage in injection drug
(B = 0.36, SE = 0.15, p = .02) and sexual risk behavior (B = .43, SE = 0.12, p < .001) at the
same time point. The PTSD factor scores at month 12 were positively associated with the
PTSD difference score (B = 0.06, SE = 0.03, p = .01) in both models. Additional timeinvariant and time-varying covariates were not added to the model, as this worsened model
fit.
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Table 3.1 Sample Characteristic at Baseline and Follow-up by Intervention Condition
Baseline

Month 3

Month 6

Month 12

Overall

HIV-Ed

HIV+MI

HIV-Ed

HIV+MI

HIV-Ed

HIV+MI

HIV-Ed

HIV+MI

(N=320)

(n=154)

(n=166)

(n=149)

(n=162)

(n=142)

(n=151)

(n=135)

(n=147)

7.0

8.5

5.5
19.5

17.9

31.7

21.9

43.0

33.0

Incarceration (%)
First incarceration
Recent incarceration
Injection Drug Risk Behavior (%)
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Lifetime injection drug use

77.2

76.0

78.3

Injection drug use

61.3

61.7

60.8

18.8

18.5

22.5

25.2

18.5

24.5

Used shared needle

50.9

49.4

52.4

14.8

13.6

20.4

19.2

17.0

21.8

Used shared works

45.9

46.1

45.8

14.1

10.5

16.9

17.2

14.8

17.0

Shared needles

47.2

47.4

47.0

10.7

9.9

14.1

13.9

8.9

15.0

Shared works

44.4

44.2

44.6

10.7

9.9

14.1

13.2

8.9

13.6

Shared equipment with partner

40.6

41.6

39.8

8.7

7.4

12.0

9.3

8.9

11.6

Did not always inject first

37.8

38.3

37.3

1.3

0.6

12.7

12.6

8.1

15.0

Unprotected vaginal sex

89.7

89.6

89.8

59.7

54.3

67.6

62.3

65.2

61.9

Unprotected anal sex

11.6

14.9

8.4

4.7

1.9

2.8

2.6

2.2

2.0

Used alcohol/drugs before sex

84.4

83.8

84.9

26.8

21.6

32.4

23.2

31.9

29.3

Last sex partner injected drugs

57.8

59.7

56.0

36.2

33.3

38.7

32.5

39.3

36.1

Traded sex for drugs/money/etc.

18.1

16.9

19.3

2.0

1.9

4.2

2.6

5.2

4.1

Sexual Risk Behavior (%)

Table 3.1 (continued) Sample Characteristic at Baseline and Follow-up by Intervention Condition
Baseline

Month 6

Month 12

Overall

HIV-Ed

HIV-Ed

HIV+MI

HIV-Ed

HIV+MI

HIV-Ed

(N=320)

(n=154)

(n=142)

(n=151)

(n=135)

(n=147)

(n=142)

Interpersonal Violence (%)
Sexual abuse

56.6

51.3

61.4

1.4

1.3

0.7

2.7

Physical abuse

85.0

89.0

94.0

9.2

6.0

8.9

5.4

Emotional abuse

91.6

85.1

84.9

14.1

12.6

16.3

13.6

Sexual, physical, emotional abuse

100.0

100.0

100.0

16.2

12.6

17.8

14.3

Possible PTSD diagnosis (%)

69.7%

63.6%

75.3%

32.4%

41.7%

37.0%

31.3%

PTSD symptoms (range 0-12)

7.14 (4.74)

6.62 (4.96)

7.63 (4.48)

3.40 (4.61)

4.17 (4.61)

3.82 (4.46)

3.29 (4.54)

Anxiety symptoms (range 0-12)

5.58 (3.66)

5.42 (3.70)

5.73 (3.63)

2.00 (2.93)

2.35 (3.26)

1.98 (2.72)

1.88 (3.07)

Depressive symptoms (range 0-9)

6.11 (2.87)

5.95 (3.00)

6.25 (2.75)

3.11 (3.12)

3.53 (3.14)

3.50 (3.00)

3.38 (3.12)

Psychiatric Symptoms (M, [SD])
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Note: HIV-Ed = NIDA Standard HIV Education; HIV+MI = Motivational Interviewing-based HIV Risk-reduction.

Table 3.2 Correlations Between PTSD, Anxiety, and Depression at Baseline and Follow-up
BL

M6

M12

BL

M6

M12

BL

M6

M12

PTSD

PTSD

PTSD

Anxiety

Anxiety

Anxiety

Depression

Depression

Depression

BL PTSD
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M6 PTSD

.02

M12 PTSD

.10

.29***

BL Anxiety

.37***

.12*

.23***

M6 Anxiety

.08

.45***

.31***

.17**

M12 Anxiety

.16**

.26***

.60***

.22***

.42***

BL Depression

.37***

.16**

.25***

.74***

.19**

.24***

M6 Depression

.12*

.38***

.27***

.14*

.74***

.31***

.16**

M12 Depression

.23**

.22***

.54***

.23***

.32***

.63***

.23***

Note: BL = baseline; M6 = Month 6; M12 = Month 12.
*p < .05. **p < .01. ***p <.001.

.38***

3.3 Deviance Tests for Unconditional and Conditional Injection Drug and Sexual Risk Behavior Models
Injection Drug Risk Behavior
-2LL, FP

χ2(df), p

Sexual Risk Behavior
-2LL, FP

χ2(df), p

Slope
Linear

-1282.94, 11

-1787.14, 9

Quadratic

-1237.28, 15

46.66 (4), p < .001

-1690.23, 13

96.91 (4), p < .001

Intervention condition

-1235.78, 18

1.50 (3), p = .68

-1689.08, 16

1.15 (3), p = .77

PTSD

-1230.39, 18

6.89 (3), p = .08

-1684.15, 16

6.08 (3), p = .11

Anxiety and depression

-1233.03, 21

4.25 (6), p = .64

-1682.46, 19

7.76 (6), p = .26

HCV seropositive status

-1433.49, 20

196.21 (5), p < .001

-1891.28, 18

201.06 (5), p < .001

Incarceration

-1657.70, 33

432.31 (18), p < .001

-2112.05, 34

421.82 (21), p < .001

Interpersonal violence

-1418.94, 28

181.66 (13), p < .001

-1874.23, 26

184.66 (13), p < .001

Time-invariant covariates
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Time-varying covariates

Note: -2LL = loglikelihood; FP = free parameters; df = degrees of freedom. Nested model comparisons (chi-square deviance tests) were used to
test fit of the linear slope against the quadratic slope, as well as each time-invariant and time-varying covariate against fit of the quadratic slope.

Table 3.4 Unconditional and Conditional Latent Growth Curve Model Estimates for the Effect of Baseline PTSD and Intervention
Condition on Injection Drug and Sexual Risk Behavior
Injection Drug Risk Behavior
Unconditional LGCM

Conditional LGCM

Sexual Risk Behavior
Unconditional LGCM

Conditional LGCM

Means and Variances
I mean

0.37 (0.09), p < .001

0.03 (0.21), p = .90

1.94 (0.14), p < .001

1.66 (0.24), p <.001

I variance

0.81 (0.42), p = .055

0.44 (0.33), p = .18

0.82 (0.26), p = .002

0.74 (0.25), p = .003
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LS mean

-4.17 (0.55), p < .001

-4.93 (1.40), p < .001

-3.11 (0.27), p < .001

-3.29 (0.63), p <.001

LS variance

10.18 (3.73), p = .006

8.14 (4.13), p = .049

5.69 (1.82), p = .002

5.34 (1.76), p = .002

QS mean

1.56 (0.27), p < .001

1.93 (0.71), p = .006

1.21 (0.12), p < .001

1.29 (0.29), p < .001

QS variance

2.34 (0.84), p = .005

1.88 (0.88), p = .03

1.17 (0.38), p = .002

1.08 (0.37), p = .003

I with LS

-0.05 (0.75), p = .95

0.03 (0.21), p = .56

-0.52 (0.46), p = .25

-0.44 (0.44), p = .32

I with QS

0.16 (0.36), p = .66

0.00 (0.30), p = .99

0.23 (0.20), p = .24

0.19 (0.19), p = .30

-2.55 (0.82), p = .002

-2.36 (0.79), p = .003

Covariance

LS with QS

-4.76 (1.73), p = .006

-3.84 (1.87), p = .04

Time-invariant Covariates
PTSD

I

Intervention

I

PTSD by Intervention
Anxiety
Depression

I
I

I

0.03 (0.02), p = .25

0.04 (0.02), p = .09

-0.32 (0.27), p = .25

-0.23 (0.28), p = .41

0.03 (0.03), p = .36

0.01 (0.03), p = .73

0.03 (0.03), p = .41

0.07 (0.03), p = .03

0.01 (0.04), p = .87

-0.05 (0.04), p = .20

Table 3.4 (continued) Unconditional and Conditional Latent Growth Curve Model Estimates for the Effect of Baseline PTSD and
Intervention Condition on Injection Drug and Sexual Risk Behavior
Injection Drug Risk Behavior
Unconditional LGCM

Conditional LGCM

Sexual Risk Behavior
Unconditional LGCM

Conditional LGCM

Time-invariant Covariates
PTSD

LS

Intervention

LS

PTSD by Intervention
Anxiety

LS
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Depression
PTSD

LS

LS

QS

Intervention

QS

PTSD by Intervention
Anxiety
Depression

QS
QS

QS

0.11 (0.10), p = .25

0.07 (0.06), p = .25

0.87 (1.25), p = .49

0.76 (0.76), p = .31

-0.09 (0.14), p = .49

-0.15 (0.09), p = .08

-0.06 (0.13), p = .67

-0.25 (0.09), p = .003

0.06 (0.17), p = .75

0.21 (0.11), p = .06

-0.07 (0.05), p = .18

-0.04 (0.03), p = .24

-0.26 (0.63), p = .68

-0.19 (0.35), p = .60

0.04 (0.07), p = .53

0.05 (0.04), p = .21

0.05 (0.06), p = .46

0.13 (0.04), p = .002

-0.04 (0.09), p = .64

-0.11 (0.05), p = .04

Note: I = intercept; LS = linear slope; QS = quadratic slope. Unstandardized estimates are shown with standard errors in parentheses.

3.5 Deviance Tests for Unconditional and Conditional PTSD Models
-2LL, FP
χ2(df), p
Slope
Linear

-3409.39, 26

Time-invariant covariates
Intervention condition

-3406.13, 28

3.26 (2), p = .20

HCV seropositive status

-3619.65, 30

210.26 (4), p < .001

Anxiety and depression

-7495.06, 71

4085.67 (54), p < .001

Incarceration

-3764.07, 37

354.68 (11), p < .001

Interpersonal violence

-3581.60, 37

172.21 (11), p < .001

Time-varying covariates

Note: -2LL = loglikelihood; FP = free parameters; df = degrees of freedom. Nested model
comparisons (chi-square deviance tests) were used to test fit of each time-invariant and timevarying covariate against the fit of the unconditional linear slope model.
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Figure 3.1 Measurement Model for Latent PTSD Symptoms at Baseline, Month 6, and
Month 12
Note: Standardized estimates are shown with standard errors in parentheses.
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Figure 3.2. Observed Proportions for Injection Drug and Sexual Risk Behavior Response
Categories
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Figure 3.3. Probability of Injection Drug Risk Behavior from Pre-incarceration to
Community Release by Intervention Condition
Note: The time-invariant covariates in this model include PTSD, anxiety and depression,
intervention condition, and a PTSD by intervention condition interaction term.
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Figure 3.4. Probability of Sexual Risk Behavior from Pre-incarceration to Community
Release by Intervention Condition
Note: The time-invariant covariates in this model include PTSD, anxiety and depression,
intervention condition, and a PTSD by intervention condition interaction term.
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Figure 3.5. Probability of Sexual Risk Behavior from Pre-incarceration to Community
Release by +/-1 Standard Deviation in Anxiety Symptoms

Note: The time-invariant covariates in this model include PTSD, anxiety and depression,
intervention condition, and a PTSD by intervention condition interaction term.
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Figure 3.6. Probability of Sexual Risk Behavior from Pre-incarceration to Community
Release by +/-1 Standard Deviation in Depressive Symptoms

Note: The time-invariant covariates in this model include PTSD, anxiety and depression,
intervention condition, and a PTSD by intervention condition interaction term.

43

Latent PTSD Symptoms

1

HIV+MI
HIV-Ed

0

-1

-2

-3
0

6

12

Months

Figure 3.7. Change in PTSD from Incarceration to Community Release by Intervention
Condition
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CHAPTER 4.

DISCUSSION

Rural Appalachian women with substance use histories are a unique and particularly
vulnerable group in need of targeted interventions aimed at reducing the spread of
HCV/HIV. Symptoms of PTSD affect a large proportion of justice-involved rural women
and may interfere with current efforts to reduce HCV/HIV risk behaviors (Staton et al.,
2017, 2018b; Weir et al., 2009). Thus, the purpose of this study was to examine HCV/HIV
risk-reduction interventions administered to incarcerated women from rural Appalachia
through a trauma-informed perspective (Facer-Irwin et al., 2019; Levenson & Willis, 2019;
SAMHSA, 2014).

4.1

Discussion of Primary Study Aims
The first aim of this study evaluated to what extent PTSD symptoms before and during

incarceration predicted HCV/HIV risk behavior following community re-entry. Overall,
women’s propensity to engage in injection drug and sexual risk behavior decreased after
being released from jail, and their rate of change slowed across time. Additionally, women
within the sample differed in their propensity to engage in HCV/HIV risk behavior before
incarceration, and they displayed heterogeneous trajectories of risk behavior following
community re-entry, supporting efforts to identify predictors of how risk behavior differs
across incarcerated women. Consistent with and extending upon prior research conducted
with women enrolled in the WISH study (Staton et al., 2018b), change in HCV/HIV risk
behavior across the re-entry period (i.e., at months 3, 6, and 12) did not differ by
intervention condition. Other studies have also found similar levels of risk reduction among
substance users when comparing the effectiveness of HIV-Ed to enhanced interventions
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involving additional counseling or culturally-informed content (Booth et al., 1998; Dushay
et al., 2001). Both the HIV+MI and HIV-Ed interventions are feasible for use in jails. A
single session of psychoeducation may be an efficient and cost-effective way to reduce
HCV/HIV risk behaviors among rural Appalachian justice-involved women.
Although prior cross-sectional research suggests higher PTSD symptoms are
associated with greater engagement in HCV/HIV risk behaviors among IV-exposed
individuals (Cavanaugh et al., 2010; Plotzker et al., 2007), our findings indicate PTSD
symptom severity leading up to and during incarceration was not associated with women’s
change in injection drug or sexual risk behavior post-release from jail (Hypothesis 1a).
Additionally, the interaction between baseline PTSD symptoms and intervention condition
was not significant (Hypothesis 1b); having higher PTSD symptoms in the year before the
baseline assessment was not associated with differences in how women responded to the
HIV+MI or HIV-Ed interventions despite there being significant variability in their rate of
change in HCV/HIV risk behavior during re-entry. Past research indicates individuals with
PTSD have poorer outcomes in substance use treatment (Kubiak, 2004; Read et al., 2004)
and benefit from enhanced monitoring while undergoing medical services for infectious
diseases (Delahanty et al., 2004; Loftis et al., 2006). Yet, our results suggest PTSD
symptoms leading up to and during incarceration may not influence the effectiveness of
brief HCV/HIV risk reduction interventions administered to IV-exposed women in rural
Appalachian jails.
The second aim of this study examined to what extent reductions in PTSD
symptom severity following community re-entry predicted subsequent reductions in
HCV/HIV risk behavior. PTSD symptoms decreased overall from baseline to community
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re-entry, but women’s change in PTSD symptoms did not differ statistically based on
which risk reduction intervention they received, although the association approached
significance (p = .052). PTSD symptoms trended toward decreasing more during re-entry
for women in the HIV+MI condition compared to women who received HIV-Ed. Past
research supports the use of motivational interviewing to attenuate risk for developing
PTSD following traumatic injury (Zatzick et al., 2004) and to enhance trauma-focused
treatment outcomes and potentially reduce PTSD symptoms among veterans (Battaglia et
al., 2016; Randall & McNeil, 2017). Although the present study’s findings did not
corroborate our prediction for Hypothesis 2a, the results provide preliminary support
suggesting further research should be conducted to specifically examine whether
HCV/HIV risk-reduction interventions that include a motivational interviewing component
may offer more promise at reducing PTSD symptoms than standard psychoeducational
interventions for IV-exposed incarcerated women. However, this finding should be
interpreted with caution since women in the HIV+MI condition started the study with more
severe PTSD symptoms than women in the HIV-Ed condition, indicating randomization
failed to yield equivalent groups at baseline on this variable. It is unclear whether the
trending effect of intervention condition on post-incarceration PTSD symptoms was due to
differences in intervention effectiveness or because women with higher PTSD severity at
baseline experienced greater symptom improvements during re-entry. We did not conduct
a sensitivity analysis for Aim 2, and it is possible the analytic methods we employed were
underpowered to assess the effect of intervention condition on change in PTSD symptoms
over the re-entry period. Future studies should ideally be designed to include sample sizes
that provide enough power to detect small but potentially meaningful effects of
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intervention condition and allow for robust comparisons among IV-exposed incarcerated
women with high, low, and absent PTSD symptoms.
Our results also failed to demonstrate that reductions in PTSD from baseline to month
6 would prospectively predict lower engagement in HCV/HIV risk behavior (Hypothesis
2b). Past research indicates individuals with PTSD often self-medicate their symptoms by
using substances or taking sexual risks (McCauley et al., 2012; Weiss et al., 2013). The
self-medication hypothesis informed our prediction that decreases in PTSD would predict
subsequent lower rates of HCV/HIV risk behavior since these behaviors may be
inextricably linked with women’s ability to cope with trauma-related distress. However,
change in PTSD post-release was not associated with subsequent HCV/HIV risk behavior,
suggesting that patterns of change in PTSD symptoms and HCV/HIV risk behavior may
unfold separately across the re-entry period for IV-exposed women. Women’s selfmedication of trauma-related symptoms may play a role during initiation or initial
exacerbation of substance use and sexual risk-taking, whereas other processes may be more
relevant when these behavioral patterns are well established (Berenz et al., 2019). For
example, symptoms of physiological withdrawal or dependence may be more likely to
maintain or promote injection drug risk behavior than self-medicating when trauma
reminders arise for IV-exposed women with long histories of substance use. Sexual risktaking may serve as a way for vulnerable women to earn financial support, obtain
substances, or to maintain safety in their sexual relationships (Mittal et al., 2013; Noska et
al., 2016; Teitelman et al., 2008), despite past research suggesting these behaviors may
also self-medicate trauma-related distress (Weiss et al., 2013). This study provides a
snapshot of rural women’s trajectories prior to and following periods of incarceration.

48

Future research should include additional assessments before, during, and following
periods of incarceration to better understand how patterns of PTSD and HCV/HIV risk
behavior unfold as women interact with the justice system.
Null findings for the primary aims may be a function of the unique sample and methods
included in this study, which were not initially designed to test the research questions
herein. The face-to-face interview used to evaluate psychiatric symptoms—the GAIN—
was originally developed for substance use treatment providers to efficiently evaluate
mental health and substance use problems to inform treatment placement and planning
(Dennis et al., 2008), and was appropriate for the needs of the parent study. However, the
GAIN does not comprehensively evaluate psychiatric disorders per criteria defined in the
Diagnostic and Statistical Manual of Mental Disorders (DSM; APA, 2013). To measure
PTSD symptomology, The GAIN TSS includes 12 items that assess several important
aspects of responses to “past events”, including nightmares and sleep problems, emotional
arousal and numbing, risk-taking and urges, anger and irritability, feelings of disconnection
from others, and self-blame. However, these items do not directly map on to the PTSD
symptom criteria defined in the DSM. More specifically, the GAIN TSS does not include
an assessment of trauma-related avoidance, memory and concentration problems,
exaggerated negative beliefs about other people or the world, and hypervigilance or startle
responses. Additionally, the GAIN TSS items are not anchored to a specific traumatic event
(or events) that involved exposure to actual or threatened death, serious injury, or sexual
violence (i.e., satisfy the definition of a Criterion A trauma in the DSM). Thus, the GAIN
TSS may not comprehensively capture IV-exposed women’s PTSD symptomology as they
transition in to and out of periods of incarceration; instead, this measure may reflect general
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distress in response to a range of significant life stressors. Future research could improve
upon these methodological limitations by including a measure that captures the frequency
and severity of potentially traumatic events (e.g., the Life Events Checklist or the Trauma
History Questionnaire; Hooper et al., 2011; Weathers et al., 2013), as well as a clinicianadministered or self-report assessment of PTSD symptoms that better reflect DSM-5
diagnostic criteria (e.g., the Clinician-Administered PTSD Scale or the PTSD Checklist for
DSM-5; Blevins et al., 2015; Weathers et al., 2018).
Another factor to consider is the distribution of baseline PTSD symptoms in the present
sample of 320 IV-exposed women, who reflect a subset of all women enrolled in the WISH
study (N = 400). Most women met criteria for “high traumatic stress” or possible PTSD
(69.7%; >5 on the GAIN TSS) at the first assessment. However, PTSD symptom scores at
baseline were bimodally distributed such that nearly half of women either reported 0
(25.0%) or all twelve symptoms (23.4%). Additionally, very few IV-exposed women had
a score between 1-4 on the GAIN TSS (5.4%). We purposefully selected IV-exposed
women to be included in the present analyses given the association between victimization
and HCV/HIV risk behavior (Mittal et al., 2013; Teitelman et al., 2008; Wagner et al.,
2009). Extending the sample to include women with other forms of trauma exposure may
yield a distribution of PTSD that better reflects the spectrum of symptom severity.
Also important to note, the time frame in which PTSD symptoms were assessed may
have been too broad to capture women’s responses to traumatic events and how they relate
to or predict HCV/HIV risk behavior. Women were asked about their PTSD symptoms in
the 12 months leading up to the baseline assessment or since the last interview at the month
6 and 12 follow-ups. It is possible that the spacing between PTSD assessments may account
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for the lack of associations between PTSD symptom severity scores at baseline and followups. An alternative possibility is that women’s PTSD symptoms may have been
exacerbated leading up to and during incarceration. Their change in PTSD during re-entry
may represent a return to normative levels, indicating that PTSD symptoms during
incarceration may not be reflective of women’s experiences of PTSD during re-entry.
Longitudinal studies are needed that include assessments of PTSD symptoms at multiple
time points prior to, during, and following periods of incarceration to understand patterns
of change in PTSD symptoms and how these patterns relate to HCV/HIV risk behavior
among IV-exposed justice-involved rural women. Additionally, future research could
expand upon the current study by comparing the trajectories of PTSD and HCV/HIV risk
behavior among IV-exposed rural women with histories of substance use and sexual risktaking who do and do not undergo periods of incarceration to understand the role that being
in jail plays on the association between PTSD and HCV/HIV risk behavior.

4.2

Exploratory Findings
In contrast with the null findings for PTSD symptoms on HCV/HIV risk behavior,

higher levels of general anxiety leading up to and during incarceration were correlated with
a higher propensity to have engaged in sexual risk behavior before incarceration and
predicted a steeper decrease in sexual risk behavior across the re-entry period. Moreover,
women with higher anxiety symptom severity at baseline experienced a more rapid
decrease in sexual risk behavior soon after release from jail, whereas sexual risk behavior
declined more steadily across the re-entry period among those with lower anxiety symptom
severity. The opposite pattern was found for depression: women with lower depressive
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symptoms at baseline experienced a steeper decrease in sexual risk behavior soon after
release from jail, and post-incarceration sexual risk-taking declined more steadily for those
with higher depressive symptoms. For women with higher anxiety or lower depressive
symptoms, sexual risk behavior initially decreased from baseline to month 6 and
subsequently increased from month 6 to month 12, resulting in no effect of anxiety or
depressive symptoms on sexual risk-taking at the last assessment. Notably, these results
were specific to sexual risk behavior, as both anxiety and depressive symptoms at baseline
were not associated with injection drug risk behavior.
Some prior studies report a positive association between sexual risk behavior and
symptoms of anxiety or depression among women (Coyle et al., 2019; Pettes et al., 2015;
Staton-Tindall et a., 2015a), whereas others report no association (Crepaz and Marks,
2001). In the present study, baseline levels of anxiety, PTSD, and depression showed strong
positive correlations indicating that general psychiatric distress was elevated leading up to
or during incarceration. However, only anxiety was associated with IV-exposed women’s
sexual risk-taking at baseline, and both anxiety and depression were related to sexual risk
behavior post-release. Anxiety symptoms may have contributed to sexual risk behavior
prior to incarceration (above and beyond PTSD and depression) and may have also led to
greater decreases in sexual risk-taking during the early stages of community re-entry.
Although this finding may seem counterintuitive, it is possible that anxiety symptoms
impaired women’s judgment and facilitated impulsive sexual decisions before
incarceration (Erez et al., 2014; Khan et al., 2009) and also prompted women to engage in
safer sex practices post-incarceration out of concern, worry, or fear of future consequences
related to their sexual behavior, particularly if said behavior was associated with the reason
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for incarceration. Anxiety symptoms are generally considered to be future-oriented,
whereas PTSD symptoms (as measured by the GAIN TSS) are characterized by to what
extent individuals are bothered by past traumatic events. Thus, symptoms of anxiety—but
not PTSD—may relate to change in sexual risk behavior since they promote concern about
future events or consequences. Continued research is needed to characterize the nature of
women’s anxiety symptoms since the measurement tool used to assess anxiety symptoms
(The GAIN AFS) provides a broad assessment of multiple anxiety-related diagnostic
categories, including generalized anxiety, panic, phobias, obsessions and compulsions,
anger, and paranoia. It is possible that worrying or concern about the future, the possibility
of being arrested again or contracting and transmitting infectious diseases, or about their
own health or the health of their partners, may be protective (i.e., associated with reductions
in sexual risk behaviors) or maladaptive (i.e., increases or has no association with sexual
risk-taking). Additionally, future longitudinal research is needed to examine whether
sexual risk behavior among women with low anxiety symptoms continues to decrease and
whether women with high anxiety symptoms experience an increase in sexual risk-taking
past the one-year mark of having re-entered into the community.
Given the unexpected association between anxiety and sexual risk behavior, we
conducted an exploratory analysis and found that intervention condition did not lead to
different associations between anxiety and post-release sexual risk behavior trajectories
(see appendix). All study participants received psychoeducation on safe sex practices,
which may have prompted women with higher anxiety symptoms to reflect on the
consequences of their sexual behavior, facilitating a short-term decrease in post-release
sexual risk-taking. However, as mentioned above, it is unclear whether the significant post-
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release decrease in sexual risk-taking among all participants is due to being incarcerated,
receiving an HCV/HIV risk reduction intervention, or a naturalistic pattern of behavior
change over time. Our results suggest that psychiatric symptoms, and specifically anxiety
and depression, may be more closely related to post-incarceration sexual risk behaviors
than injection drug risk behaviors. Women were enrolled in the study if they had a history
of using substances and were (at least) in moderate need of a substance use intervention.
Prevention and treatment strategies aimed at reducing sexual risk behaviors among
vulnerable justice-involved women with substance use histories may benefit from
integrating evidence-based strategies that address anxiety symptoms, whereas
interventions for injection drug risk behavior may focus on addressing symptoms of
addiction (e.g., tolerance, withdrawal, physiological dependence). Our results also
highlight the need to explore alternative or additional interventions, such as anxietyfocused treatments or booster sessions during re-entry, particularly for women with high
anxiety symptoms before and during incarceration.

4.3

Implications, Limitations, and Directions for Future Research
The present study’s findings have important implications for providing mental and

behavioral healthcare to incarcerated rural Appalachian women with histories of substance
use, sexual risk behavior, and IV. As described above, women’s overall engagement in
HCV/HIV risk behavior and PTSD symptoms decreased following release from jail.
However, the study design precludes our ability to state whether change in risk behavior
and PTSD symptoms is due to the brief HCV/HIV risk reduction interventions women
received or to periods of or release from incarceration. Despite the overall decrease in risk
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behavior, many women engaged in at least one form of injection drug (18-24%) or sexual
risk behavior (54-67%) after re-entering into the community. Additionally, 31-41% of
women continued to meet criteria for possible PTSD (>5 symptoms on TSS) postincarceration, a rate that is substantially higher than estimates from the general U.S.
population (10%; Mitchell et al., 2012). Rural Appalachian women who engage in
HCV/HIV risk behaviors or experience PTSD symptoms post-release may benefit from
psychosocial support or treatments beyond what was provided in the WISH study while in
jail or following community re-entry.
Establishing predictors of intervention response is an important area of research and
can help providers make informed decisions regarding which intervention is appropriate at
what dose and for whom. Some IV-exposed women may benefit from brief behavioral risk
reduction interventions offered during incarceration, whereas others may require more
intensive interventions, including evidence-based trauma-informed interventions or PTSDspecific treatments. Trauma-informed interventions promote awareness of the impact
trauma exposure has on the individual and typically include strength-based approaches that
promote recovery, resilience, and overall wellness by teaching cognitive and behavioral
skills. Several trauma-informed interventions have been successfully administered in jails
and prisons and demonstrate reductions in PTSD symptoms, substance use, and sexual risktaking (Hien et al., 2010; see King, 2017 for a review). However, to the authors’
knowledge, the effectiveness of “gold standard” psychological treatments that specifically
target PTSD symptoms has yet to be tested among currently incarcerated or imprisoned
populations (Harner et al., 2015). One study examining the effect of a group-based PTSDspecific treatment (e.g., Cognitive Processing Therapy) among imprisoned men and
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women has recently completed data collection, and results are forthcoming (Koenigs,
2019). PTSD-specific treatments require clinicians to receive specialized training and are
typically offered over the course of 12-16 weeks (Lancaster et al., 2016). Although
possible, these factors make the widespread implementation of PTSD-specific treatments
in jail settings improbable due to the transient nature of the population and limited
resources available. Important future directions are to identify who will benefit from brief
behavioral interventions, who needs (or would prefer) additional or alternative traumafocused care, and when is the optimal time to administer the interventions.
Future research should investigate rural Appalachian women’s uptake of
behavioral and medical healthcare after being released from jail. Past research by Dushay
and colleagues (2001) suggests that although there was no difference in HCV/HIV risk
reduction between the HIV-Ed and an enhanced culturally-informed intervention
administered to substance users in the community, individuals who enrolled in substance
use treatment services in the six months following the interventions demonstrated greater
reductions in risk behavior at follow-up than those who did not. Women in the present
sample were not seeking mental or behavioral health treatment when they enrolled in the
study but were given a list of local health services in rural Appalachia as part of
psychoeducation. Unlike treatment-seeking samples, women in the current study may have
presented with varying levels of motivation to change their injection drug and sexual risk
behaviors or engage in services during community re-entry. Examining the uptake of
mental and behavioral health treatment after women are released from jail may help to
elucidate factors that explain the variability in women’s propensity to engage in HCV/HIV
risk behaviors during re-entry, especially considering the geographic barriers to health care
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services and stigma against help-seeking that Appalachian women face. Other notable
factors to consider are women’s perceptions of HCV/HIV risk behaviors, their ability to
obtain stable housing and employment, as well as the quality of their social support
networks and level of caretaking responsibilities following release from jail (Clone et al.,
2014; Staton-Tindall et al., 2015b; Visher & Bakken, 2014).
Although findings from this study are not generalizable to men, women of color, and
individuals outside of rural Appalachia or without justice involvement, this study focuses
on a population—justice-involved rural Appalachian women with IV histories—that is at
risk for deleterious health consequences and, until recently, has not been a focus of
HCV/HIV prevention efforts. Experiences of physical, sexual, and emotional abuse are
ubiquitous among rural Appalachian women who use substances (Shannon et al., 2016;
Staton et al., 2018b) and may be perceived by these women as normal or unavoidable.
Since IV-exposed women may have a poorer perceived ability to negotiate safe injection
and sex practices with their intimate partners (Mittal et al., 2013; Teitelman et al., 2008;
Wagner et al., 2009), it is possible that women who transition back into relationships with
partners that perpetrate IV may be at increased risk for HCV/HIV following release from
jail. Designing strength-based HCV/HIV risk reduction interventions that explicitly target
the cultural values of self-reliance and resiliency promoted by Appalachian communities
(Helton & Keller, 2010) may foster women’s empowerment in their romantic relationships
and increase their perceived ability to safely engage in HCV/HIV behaviors.
In addition to the aforementioned ways future research can expand upon the
methodological limitations of the present study, several other improvements should be
considered. First, PTSD symptoms were only measured at three time points, which
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precluded our ability to model non-linear change, as well as to conduct a more nuanced
analysis evaluating how reductions in PTSD symptoms predict reductions in HCV/HIV
risk behavior following release from jail. Increasing the number of assessments could boost
statistical power for advanced analyses modeling the parallel process of change in PTSD
and HCV/HIV risk behavior over time (Little, 2013). Additionally, longitudinal studies
with multiple assessments of PTSD symptoms prior to, during, and following periods of
incarceration could elucidate patterns of change in PTSD symptoms among IV-exposed
justice-involved rural women with substance use histories. Second, the interview used to
assess PTSD, anxiety, and depression—the GAIN—was based on the fourth edition of the
DSM but was not a formal diagnostic assessment. Future research evaluating psychiatric
conditions among justice-involved women may consider using clinician-administered
assessments or self-report measures that are based on criteria in the updated fifth edition of
the DSM to increase diagnostic precision. However, increasing the number of assessments
and including formal diagnostic measures should be carefully weighed against the added
participant burden. Third, the present study did not have a control condition, which
precludes our ability to draw definitive conclusions regarding the impact of brief HCV/HIV
risk reduction interventions above and beyond periods of or release from incarceration.
Additionally, we are not able to discern whether women in the sample benefited from
HCV/HIV interventions specifically or whether they would have benefited from any
intervention at all. Future research could explore to what extent periods of incarceration
alone may facilitate changes in HCV/HIV risk behaviors, given that individuals in jail are
often separated from environments where injection and sexual risk behaviors occur.
However, excluding a control condition is a common practice when testing efficacious
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interventions in real-world settings (Buchanan et al., 2007), given the ethical concerns for
withholding interventions that may be beneficial to at-risk or vulnerable individuals.

4.4

Conclusions
This study addresses a critical gap in efforts to reduce injection drug and sexual

risk behavior among IV-exposed rural Appalachian women with substance use histories—
a uniquely vulnerable and disadvantaged population at high risk for deleterious health
outcomes—by examining brief HCV/HIV interventions through a trauma-informed
perspective. Our findings indicate PTSD symptoms were not associated with women’s
change in injection drug or sexual risk behavior after community re-entry. Moreover,
women’s change in HCV/HIV risk behavior after being released from jail did not differ
based on whether they received brief psychoeducation or a motivational interviewingbased intervention while incarcerated. PTSD symptoms trended toward decreasing more
during re-entry for women who received a motivational-interviewing enhanced
intervention compared to women who received psychoeducation alone, although this
should be interpreted with caution. An unexpected finding was that anxiety and depressive
symptoms prior to and during incarceration were associated with different trajectories of
change in sexual, but not injection drug, risk behavior post-release. The results of this study
add to a growing literature aimed at developing targeted prevention and intervention efforts
for reducing HCV/HIV risk behaviors among justice-involved rural Appalachian women.
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APPENDIX
Supplemental Table. Conditional Latent Growth Curve Model Estimates for the Effect of
Baseline Anxiety and Intervention Condition on Sexual Risk Behavior
Sexual Risk Behavior
Conditional LGCM
Means and Variances
I mean

1.72 (0.25), p < .001

I variance

0.74 (0.25), p = .003

LS mean

-3.08 (0.63), p < .001

LS variance

5.40 (1.77), p = .002

QS mean

1.21 (0.29), p < .001

QS variance

1.09 (0.37), p = .003

Covariance
I with LS

-0.43 (0.44), p = .33

I with QS

0.19 (0.19), p = .30

LS with QS

-2.40 (0.79), p = .002

Time-invariant Covariates
PTSD

I

0.05 (0.02), p = .008

Intervention

I

Anxiety by Intervention
Anxiety

I

-0.05 (0.04), p = .24

LS

-.003 (0.05), p = .95
LS

Anxiety by Intervention
Anxiety

025 (0.76), p = .74
LS

LS

Depression

LS

Intervention

0.20 (0.11), p = .08
-0.01 (0.22), p = .67

QS

Anxiety by Intervention

Depression

-0.11 (0.12), p = .35
-0.18 (0.11), p = .09

QS

Anxiety

0.05 (0.04), p = .35
0.05 (0.04), p = .25

Intervention

PTSD

I

I

Depression
PTSD

-0.36 (0.28), p = .19

QS

0.02 (0.35), p = .97
QS

0.03 (0.05), p = .56
0.11 (0.05), p = .04

QS

-0.10 (0.05), p = .05

Note: I = intercept; LS = linear slope; QS = quadratic slope. Unstandardized estimates are
shown with standard errors in parentheses.
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